Overview
LUX Med Onkologia provides cancer diagnostics and treatment under Poland’s NFZ system, including inpatient and outpatient care. Its services also include clinical trials, drug programs, and rapid cancer therapy.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Pool Physiotherapy under NFZ at the LUX MED Oncology Rehabilitation Center
We Invite Endoscopists to Work at LUX MED Oncology!
Info Kiosks Closed for Several Additional Weeks
We Invite Anesthesiologists to Work at LUX MED Oncology!
We Invite You to OnkoCafe Patient Club Meetings!
Plan to Merge LUX MED Oncology with LUX-MED INVESTMENT
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-01-01. Active
09 1020 1026 0000 1802 0466 1809- 58 1020 1026 0000 1102 0305 5241
- 69 1020 1026 0000 1102 0304 6216
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 17, 2025 | Merger registered | |
| Sep 10, 2024 | Merger registered |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 20, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $8,490 | Marszałek Województwa Mazowieckiego |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The following are authorised to make declarations of will on behalf of the company: (i) the President of the Management Board and another member of the management board acting jointly, or (ii) the Vice-President of the Management Board for Financial Affairs and another member of the management board acting jointly.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Lux Med Sp. z o.o. | 868,209 | $11,726,215.56 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Iwona Balcerowska (46)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Magdalena Anna Bizoń (38) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Roman Marek Wylezol (54) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| PZU ZdrowieS.A. | $304,464,409.93 | pzuzdrowie.pl | |
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | |
| Szpital Specjalistyczny Im. Ludwika Rydygiera w Krakowiesp. z o.o. | $237,332,771.76 | szpitalrydygier.pl | |
| Miedziowe Centrum ZdrowiaS.A. | $75,720,015.92 | mcz.pl | |
| Mazowiecki Szpital Onkologicznysp. z o.o. | $72,929,509.74 | szpitalonkologiczny.pl | |
| Nutrimedsp. z o.o. | $64,888,288.93 | nutrimed.pl | |
| VoxelS.A. | $53,719,762.23 | voxel.pl | |
| Centrum Medyczne Luxmedsp. z o.o. | $56,441,775.45 | luxmed.pl | |
| Szpital Czerniakowskisp. z o.o. | $53,133,134.99 | szpitalczerniakowski.waw.pl | |
| Sosnowiecki Szpital Miejskisp. z o.o. | $47,399,674.90 | szpital.sosnowiec.pl |
Change history
| Date | Event |
|---|---|
| 2024-08-30 | Share capital change (38,301,100.00 PLN → 43,410,450.00 PLN) |
| 2020-10-29 | Name change (Lux Med. Onkologia → Lux Med Onkologia) |
| 2020-10-14 | Address change (Ul. Gen. Augusta Emila Fieldorfa "nila" 40, 04-125, Warszawa → Ul. Szamocka 6, 01-748, Warszawa) |
| 2020-10-14 | Name change (Magodent → Lux Med. Onkologia) |
| 2020-03-18 | Share capital change (5,891,050.00 PLN → 38,301,100.00 PLN) |
FAQ
Last updated: 2026-07-04